Yu Shan

Founder at SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.

Net worth: 54 M $ as of 30/03/2024

64 year

99 connections

Consumer Services

Health Technology

Process Industries

Profile

Yu Shan founded Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Presently, he is General Manager & Executive Director at Shenzhen Hepalink Pharmaceutical Group Co., Ltd. and Executive Partner at Urumqi Shuidishichuan Equity Investment Partnership LP. He is also on the board of Chengdu Hepatunn Pharmaceutical Co. Ltd. and Shenzhen Duopule Industrial Development Co., Ltd. He received an undergraduate degree from Peking University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. CLASS A 3.72%	29/06/2023	46,425,600 ( 3.72% )	54 M $	30/03/2024

Yu Shan active positions

Companies	Position	Start
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.	Founder	20/04/1998
Urumqi Shuidishichuan Equity Investment Partnership LP	Corporate Officer/Principal	-
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The private company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million.	Director/Board Member	-
Shenzhen Duopule Industrial Development Co., Ltd. Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million.	Director/Board Member	12/01/2014

All active positions of Yu Shan

Training of Yu Shan

Peking University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Yu Shan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.	Health Technology

Private companies	3
Urumqi Shuidishichuan Equity Investment Partnership LP
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The private company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million.	Process Industries
Shenzhen Duopule Industrial Development Co., Ltd. Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million.	Distribution Services

See company connections